Pharmacy benefit management unicorn Capital Rx rakes in $3.5 billion in revenue as Congress targets drug middlemen

Pharmacy benefit management unicorn Capital Rx rakes in $3.5 billion in revenue as Congress targets drug middlemen

Andrii Zastrozhnov/Getty Images

Pharmacy benefit management startup Capital Rx earned $3.5 billion in revenue last year as Congress sought to reign in the legacy middlemen that have long profited from high drug costs.

No comments

Read more